Survey: Did the FDA Jump the Gun?

The FDA announced yesterday that studies of two prescription proton-pump inhibitors, omeprazole (Prilosec) and esomeprazole (Nexium), had raised concerns about their cardiovascular safety. In the same announcement, the agency said its preliminary assessment was that the problems seen in those studies were "not a true effect." But a final safety report remained three months away.